{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:38:39Z","timestamp":1778179119026,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cllc.2012.10.003","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T02:02:48Z","timestamp":1357264968000},"page":"418-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Wei-Yu","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Yuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Yuh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Chi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Chih-Hsin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2012.10.003_bib1","series-title":"Murray and Nadel's Textbook of Respiratory Medicine","first-page":"1371","article-title":"Bronchogenic carcinoma","author":"Silvestri","year":"2005"},{"key":"10.1016\/j.cllc.2012.10.003_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.128.1.452","article-title":"Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003","volume":"128","author":"Yang","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2012.10.003_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.lungcan.2006.05.024","article-title":"Is trimodality approach better than bimodality in stage IIIA, N2 positive non-small cell lung cancer?","volume":"53","author":"Park","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0003-4975(10)64717-0","article-title":"The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis","volume":"46","author":"Naruke","year":"1988","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2012.10.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)37318-0","article-title":"Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with respectable cancer of the lung","volume":"83","author":"Pearson","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2012.10.003_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5223(19)35631-4","article-title":"The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung: a commentary","volume":"99","author":"Shields","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2012.10.003_bib7","first-page":"2638","article-title":"Combined modality therapy of lung cancer","volume":"3","author":"Livingston","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.10.003_bib8","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2393::AID-CNCR31>3.0.CO;2-Q","article-title":"Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): analysis of cancer and Leukemia Group B protocol 8935","volume":"77","author":"Kumar","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-5223(95)70278-4","article-title":"Results of Cancer and Leukemia Group B protocol 8935: a multiinstitutional phase II trimodality trial for stage IIA (N2) non-small-cell lung cancer","volume":"109","author":"Sugarbaker","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2012.10.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(98)00046-4","article-title":"Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer","volume":"21","author":"Roth","year":"1998","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-5002(99)00045-8","article-title":"Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial","volume":"26","author":"Rosell","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib12","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0003-4975(93)91072-U","article-title":"Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients","volume":"55","author":"Martini","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2012.10.003_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/JTO.0b013e3181cd3345","article-title":"Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials","volume":"5","author":"Song","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bjc.6603075","article-title":"Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study","volume":"94","author":"Betticher","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib15","first-page":"247","article-title":"Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer","volume":"20","author":"Depierre","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"Betticher","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl 11","key":"10.1016\/j.cllc.2012.10.003_bib17","first-page":"13","article-title":"Overview of docetaxel (Taxotere)\/cisplatin combination in non-small cell lung cancer","volume":"26","author":"Le Chevalier","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jjco\/hye019","article-title":"Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients","volume":"31","author":"Ohe","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2012.10.003_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2004.06.114","article-title":"Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group","volume":"22","author":"Kubota","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib21","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2003.12.046","article-title":"Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group","volume":"21","author":"Fossella","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.lungcan.2007.01.011","article-title":"A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemonaive non-small-cell lung cancer in Taiwan","volume":"56","author":"Chen","year":"2007","journal-title":"Lung Cancer"},{"issue":"suppl 2","key":"10.1016\/j.cllc.2012.10.003_bib23","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0169-5002(04)80038-2","article-title":"Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer","volume":"46","author":"Betticher","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00129689-200204000-00006","article-title":"Video-assisted thoracoscopic surgery for diagnosis, staging, and management of lung cancer with suspected mediastinal lymphadenopathy","volume":"12","author":"Brega Massone","year":"2002","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.cllc.2012.10.003_bib25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1200\/JCO.2006.09.8251","article-title":"Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer","volume":"25","author":"Di Maio","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: basic concepts and first analyses","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.lungcan.2005.01.002","article-title":"Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature","volume":"49","author":"Berghmans","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ejca.2006.01.049","article-title":"Docetaxel and cisplatin as induction chemotherapy in patients with pathologically proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer (EORTC 08984)","volume":"42","author":"Biesma","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib29","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"Albain","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-5002(97)00658-2","article-title":"Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer","volume":"17","author":"Elias","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2004.06.004","article-title":"Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto Phase II Trial","volume":"47","author":"Burkes","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.10.003_bib32","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1378\/chest.128.3.1442","article-title":"Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French Trial database","volume":"128","author":"Milleron","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2012.10.003_bib33","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0b013e318189f551","article-title":"The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review","volume":"3","author":"Hirsch","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2012.10.003_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/JTO.0b013e31824c7d92","article-title":"Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials","volume":"7","author":"Mouillet","year":"2012","journal-title":"J Thorac Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:03:14Z","timestamp":1761505394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730412002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1525730412002513"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2012.10.003","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2012.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}